To Top

Search By Topic

Business

62 Articles available
Pricing

More Price Hikes Coming from Pfizer Next Year

PAO-M11-18-NI-018
Equipment

Procuring Equipment at the Speed of Business

PAO-M10-18-CL-001
Collaboration

Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial

PR-M09-18-NI-071
Acquisition

Ziylo Acquired by Novo Nordisk in Deal That Could Exceed US$800m

PR-M09-18-NI-069
Investment

J&J Anticipates Growth

PAO-M09-18-NI-014
Acquisition

Stratford Pharmaceuticals, LLC Acquired by Eli Global

PR-M09-18-NI-055
Artificial Intelligence

WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies

PR-M09-18-NI-054
Collaboration

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

PR-M09-18-NI-052
Collaboration

RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells

PR-M09-18-NI-049
Acquisition

Portage to Acquire SalvaRx Limited

PR-M09-18-NI-042
Investment

AxiaMed Announces $12.4 Million Capital Investment Led By Health Enterprise Partners

PR-M09-18-NI-036
Strategic Collaboration

Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda

PR-M09-18-NI-035
Drug Development

The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

PR-M09-18-NI-030
Acquisition

Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.

PR-M09-18-NI-028
Acquisition

Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

PR-M09-18-NI-011
Licensing Agreement

Cancer Prevention Pharmaceuticals Completes North American Licensing Deal with Mallinckrodt

PR-M09-18-NI-008
Neuroprotective Therapies

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

PR-M09-18-NI-004
Generics

FDA Approves First Generic Drug Under New Pathway Aimed at Enhancing Market Competition for Sole Source Drugs

PR-M08-18-NI-108
Acquisition

Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-Based Drug Discovery, For Approximately $43 Million in Cash

PR-M08-18-NI-107
Collaboration

OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company

PR-M08-18-NI-102
Business

Perrigo to Divest Its Prescription Drug Business

PAO-M08-18-NI-015
Market Intelligence

Forces Driving Growth in the U.S. Surgical Microscopes Market

PAO-08-18-CL-001
Investment

Investing in Chinese Pharma Companies Proves Profitable

PR-M05-18-NI-023
Mergers & Acquisitions

Inside Mergers & Acquisitions

PAP-Q2-18-CL-001
Investment

Taking Middle-Market CROs and CDMOs to the Next Level

PAP-Q2-18-CL-003
Corporate Social Responsibility

Corporate Social Responsibility as a Driver for Improved Sustainability

PAP-Q2-18-CL-014
Cell and Gene Therapy

Oxford BioMedica is Making Big Moves

PAO-M03-18-NI-012
Strategic Collaboration

Driving Change in the Pharma Industry and Biotech One Relationship at a Time

PAP-Q1-18-CL-004
Business

DSM Sinochem Pharmaceuticals Is for Sale

PAO-M03-18-NI-009
Business

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

PR-M01-18-NI-009
Business

PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors

PR-M01-18-NI-007
Business

Cue Biopharma Announces Closing of Initial Public Offering

PR-M01-18-NI-003
Clinical Trials

Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018

PR-M01-18-NI-002
Immuno-Oncology Therapies

ARMO BioSciences Files Registration Statement for Proposed Initial Public Offering

PR-M01-18-NI-001
Business

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

PR-M12-17-NI-010
Business

Bio-Rad Authorizes New $250 Million Share Repurchase Program

PR-M11-17-NI-017
Drug Development

Vetter’s Opens a New Office in South Korea

PAO-M11-17-NI-032
Business

Grand River Aseptic Manufacturing Announces Majority Investment by Arlington Capital Partners

PR-M11-17-NI-014
Expanded Capacity

AbbVie Starts Up New Mammalian Cell-Culture Production Facility in Singapore

PAO-M11-17-NI-019
Expanded Capacity

Eli Lilly Expands Insulin Production Capacity in Indiana

PAO-M11-17-NI-018
CAR T

Mustang Bio Sends CAR T Cell Therapy Line to College

PAO-M11-17-NI-003
CRO

Factory CRO Acquires MileStone Research Organization, Builds North American Presence

PR-M10-17-NI-010
Generics

Merger to Create Large US Generics Firm

PAO-M10-17-NI-042
Market Penetration

Russian biotechnology company «BIOCAD» prepares to enters the European market.

PR-M10-17-NI-009
Capacity Expansion

Janssen Expands Biomanufacturing Capabilities in Ireland

PAO-M10-17-NI-031
Drug Pricing

California Moves to Increase Transparency of Prescription Drug Pricing

PAO-M10-17-NI-030
CDMO

Servier CDMO Expands Preparative Chromatography Platform At Normandy Site To Support Market Need

PR-M10-17-NI-007
CDMO

CDMO Pfizer CentreOne Expands Contract Manufacturing To Nagoya, Japan

PR-M10-17-NI-006
Innovation

GSK’s Flonase Goes to Market with Smart Shelf Solution

PAO-M10-17-NI-010
Capacity Expansion

Ajinomoto Althea Set to Open New Capacity in San Diego

PAO-M09-17-NI-029
Facility

Alcami Announces Grand Opening of St. Louis, Missouri Facility In Cortex Innovation Community

PR-M09-17-NI-003
Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

PAP-Q3-17-NO-001
Expansion

Alcami Establishes New Center of Excellence

PAO-M09-17-NI-018
Global Partners

Building the Foundation of Japan’s Premier CDMO

PAP-Q3-17-CL-006
Pharma 2020

Russian Pharma Market Offers Great Potential for Local Manufacturers

PAP-Q3-17-CL-004
Serialization

UPM Pushes Forward with Serialization Efforts

PAO-M09-17-NI-017
Business

US Spending on Medicines Slows by Half, According to Study

PAO-M05-17-NI-017
CDMO

Relay Therapeutics Tags Sanjiv Patel for CEO Position

PAO-M04-17-NI-006